Highest-materiality recent filing
LifeMD Q1 revenue $50.2M beats guidance; adds 42k subscribers, record GLP-1 signups
Revenue $50.2M vs guidance $48-49M; adj. EBITDA loss $4.5M in line.
LifeMD appoints new CFO, promotes CBO and CMO; outgoing CFO to advise
CFO Marc Benathen resigns effective March 31, 2026; will provide advisory services for 6–12 months at $38,117/month.
LifeMD FY2025 rev $194.1M (+25%), adj EBITDA $15.3M (+309%); guides to >$250M run-rate by Q4 2026
FY2025 revenue $194.1M (+25% YoY); adjusted EBITDA $15.3M (+309% YoY).
LifeMD closes $50M revolving credit facility with Citizens Bank, N.A.
Facility provides $30M committed plus $20M accordion; maturity January 2, 2029.
LifeMD Q3 revenue $60.2M (+13%), adj EBITDA $5.1M; paid off debt, sold WorkSimpli
Total revenue $60.2M (+13% YoY); adjusted EBITDA $5.1M (+20% YoY).
LifeMD delays Q3 earnings, expects late 10-Q filing due to $4.6M revenue recognition corrections
Q3 2025 earnings rescheduled to Nov 17, 2025; expects to file Form 12b-25 for late 10-Q.
LifeMD sells majority stake in WorkSimpli for $65M enterprise value; receives $22M cash at close
Sold 80% of WorkSimpli units to buyer group led by founder/CEO; enterprise value ~$65M.
LifeMD dismisses CBIZ CPAs, appoints PwC; cites material weaknesses in internal controls
On Aug 15, 2025, LifeMD dismissed CBIZ CPAs (appointed Apr 24, 2025) as auditor; no disagreements.
LifeMD Q2 revenue up 23% to $62.2M, adjusted EBITDA up 223% to $7.1M; revises FY2025 guidance
Total revenue $62.2M (+23% YoY), telehealth revenue $48.6M (+30%); telehealth adjusted EBITDA $3.4M (+560%).
LifeMD appoints Shayna Webb Dray as COO; promotes two other executives
Appointment of Shayna Webb Dray as COO effective March 27, 2025; base salary $400K, 100,000 RSUs with time and performance vesting.
LifeMD shareholders elect seven directors, ratify auditor at annual meeting
Elected directors: Justin Schreiber, Dr. Joseph DiTrolio, Roberto Simon, John Strawn, Dr. Joan LaRovere, William Febbo, Dr. Calum MacRae.
LifeMD Q1 revenue up 49% to $65.7M; first GAAP profit; raises FY 2025 guidance
Total revenue $65.7M (+49% YoY); telehealth revenue up 70% to $55.8M.
LifeMD acquires Optimal Human Health MD assets for 100k shares; launches women's health vertical
Acquired key assets from Optimal Human Health MD for 100,000 shares of common stock (50k at close, 50k at 1yr) plus earn-out.
LifeMD replaces auditor Marcum with CBIZ; cites material weaknesses in internal controls
Marcum LLP resigned as independent auditor on April 24, 2025; CBIZ CPAs P.C. appointed same day.
LifeMD Q4 revenue $64.3M (+43% YoY), adj EBITDA $9.0M; FY2025 rev guidance $265-275M
Q4 2024 revenue $64.3M (+43% YoY); telehealth revenue $49.9M (+60%); GAAP net loss narrowed to $0.9M from $4.5M.
LifeMD raises CEO Justin Schreiber's base salary to $500,000 effective Jan 1, 2025
Chairman and CEO Justin Schreiber's annual base salary increases from $300,000 to $500,000, effective January 1, 2025.
LifeMD board member Robert Jindal to resign effective Dec 31, 2024
Robert Jindal voluntarily resigned from LifeMD's board, effective December 31, 2024.
LifeMD director Naveen Bhatia resigns from board effective Oct 25, 2024
Naveen Bhatia voluntarily resigned from LifeMD's board of directors.
LifeMD stockholders approve 3M share increase in 2020 equity plan; all director nominees elected
Approved Third Amended and Restated 2020 Equity Plan, increasing share reserve by 3,000,000 shares (13,225,022 for, 8,347,423 against).
LifeMD appoints Dr. Calum MacRae, Harvard cardiologist, to board
Dr. MacRae appointed as independent director effective April 26, 2024.
Effective October 25, 2024, Naveen Bhatia voluntarily resigned from his position as a member of the board of directors (the “Board”) of LifeMD, Inc. (the “Company”).
On April 26, 2024, Calum MacRae was appointed to the Board of Directors.
Max materiality 0.80 · Median 0.65 · Most common event earnings